Google Übersetzer
Kairos Pharma, Ltd.
About
Kairos Pharma, Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 2 2026
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Feb 26 2026
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
Jan 20 2026
Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference
Dec 17 2025
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
Nov 4 2025
Kairos Pharma Provides Shareholder Update